retatrutide fda approval date Weight Loss Results:Trial Data and Status FDA Warns Companies Over Compounded

Propensity score matching (PSM) was carried out to match age, sex, race, ethnicity, presence of HTN, DM, use of immunosuppressive medications, use of SGLT2 inhibitors, smoking, obesity and statin use

independent Janoshik report on selected lots For research purposes only

2023;35:1038e10568

GLP-1 medications target appetite but your dietitian targets long-term behavior change

Many people using GLP-1 weight loss drugs may not be eating enough nutritious food. May 19, 2025

Labeled uses include treatment of type 2 diabetes as an addition to diet and exercise, and use in certain adults with heart failure or chronic kidney disease to reduce defined risks